Abstract: The wide use of antibiotics and development of new broad-spectrum antibiotics have resulted in serious drug resistance of bacteria, which is one of the important public health problems in the globe. Nosocomial infection of methicillin-resistant Staphylococcus aureus (MRSA) is common and duo to its multi drug resistance and proneness to spread, the treatment of MRSA infection is diffucult. Not only the nosocomial infection of MRSA infection is seriuos, but also the community acquired infection of MRSA is in increase. Vancomycin-resistant Staphylococcus aureus (VRSA) has emerged in foreign countries, which is called super-bacteria (Superbug) or silent killer. This paper summerizes the progress in the research of the nosocomial infection of MRSA and in the prevetnion and treatment of MRSA infection.